Exploring intricate settings for advancement

Synthace, a multidisciplinary team of computer scientists, biologists, mathematicians, and chemists, is making waves in the biotechnology and pharmaceutical industries. The company is partnering with leading companies worldwide, aiming to revolutionize the sector's ability to innovate.

The director of strategic partnerships at Synthace, Sybil Wong, underscores the importance of allowing scientists to focus on designing and analyzing experiments, rather than on their execution. Synthace's innovative approach frees up research scientists to focus on the 'why' instead of the 'how'.

Synthace's flagship product, the cloud-based platform Antha, was developed to address this very issue. Antha transforms Design of Experiments (DOE) input into instructions for automated liquid handlers and provides structured data sets ready for immediate analysis. This user-friendly environment requires no programming knowledge, empowering researchers with digital tools and flexible automation to tackle the problem of biological complexity.

Antha's integration with JMP, a powerful and flexible DOE tool, offers easy-to-use visual and statistical exploration of scientific data. This combination enables Synthace's clients to greatly reduce the time to the correct decision, enabling the opportunity to make significantly lower-cost, more effective drugs.

DOE is a holistic and statistical approach to studying biological systems that simultaneously considers multiple factors and their interactions. By using DOE, biotech firms can deliver insights more quickly, demonstrating reliability, scalability, and accountability that organizations need from their research and development teams.

Synthace's approach can help optimize the design of biological assays and processes, enabling scientists to gain reproducible and more robust insights. In fact, Synthace has achieved impressive results for its partners. For one partner, Synthace achieved a greater than 90% time saving in planning, execution, and data aggregation for characterizing a spectrophotometric enzymatic assay using a space-filling DOE with 3,456 runs. Another customer benefited from an 83% time saving from combined design, planning, and physical execution, and a 32% resource saving.

Synthace is hosting a webinar on 1 September 2020 at 12pm (BST) to demonstrate how to transform new product development processes. If you're a scientist looking to streamline your work and focus on the science, rather than the manual execution or programming, Synthace's Antha platform could be the solution you've been waiting for.

In Synthace's vision of the future, scientists' innate capabilities will be augmented with the right digital tools, facilitating wider use of DOE. This will allow scientists to achieve rapid results and find solutions to the world's biggest challenges. With Synthace, the future of biotech is digital, efficient, and innovative.